On 7 December, the European Commission welcomed the adoption of important new measures which will enable Member States to relieve EU hospitals, medical practitioners and individuals of Value-Added Tax (VAT) when acquiring coronavirus vaccines and testing kits.

The new rules, adopted unanimously by all Member States and based on a Commission proposal of 28 October (as part of the Communication on additional COVID-19 response measures), are designed to give better and cheaper access to the tools needed to prevent, detect and treat coronavirus.

The measures will allow EU countries to put in place a temporary VAT exemption for vaccines and testing kits being sold to hospitals, doctors and individuals, as well as closely related services.

Source & full text: European Commission